NIH announces new ethics rules
NEWS IN BRIEF — Posted Feb. 28, 2005
In response to investigations that revealed some National Institutes of Health scientists were profiting from consulting jobs with pharmaceutical and biomedical companies, the NIH announced new ethics regulations for its employees.
The new rules prohibit NIH scientists from holding stock or performing outside work for pharmaceutical and biotechnology companies, an NIH press release stated. They also ban NIH scientists from working for research institutions supported by such companies, and prohibit them from working for health care providers, insurers, and related trade and professional associations.
They are, however, able to continue outside academic activities including teaching and writing scientific reviews and textbooks.
Note: This item originally appeared at http://www.ama-assn.org/amednews/2005/02/28/prbf0228.htm.